Critical Diagnostics Release: Study Shows Biomarker ST2 Can Help Hospitals Reduce Both Rates of Rehospitalization and Death for Heart Failure Patients

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics announced today the release of a company-sponsored white paper from BioBridge Strategies, LLC which demonstrates the reduction of 30-day hospital re-admission rates and mortality in cardiovascular disease patients can be accomplished through a comprehensive disease management strategy that includes use of the biomarker ST2—resulting in better patient outcomes, direct cost savings and improved quality scores for hospitals. Link: http://criticaldiagnostics.com/dmstrategy.